From: An Expanding Role for Interleukin-1 Blockade from Gout to Cancer
Disease | References |
---|---|
Schnitzler syndrome | 43,195–208 |
Behçet disease | 147,209,210 |
Secondary amyloidosis | 43,107,143,146,147,157,211–214 |
Henoch-Schönlein purpura | 215 |
Idiopathic recurrent pericarditis | 157,171,216–220 |
Systemic-onset juvenile idiopathic arthritis | 22,33,102,106,107,221–224 |
Adult-onset Still disease | 36–39,225–243 |
Macrophage activation syndrome | 46–50,55,244–247 |
Sweet syndrome (neutrophilic dermatoses) | 186,248–250 |
Neutrophilic panniculitis | 244,245,251 |
Erdheim-Chester (histiocytoses) | 252–254 |
SAPHO syndrome | 255–257 |
Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA) | 258,259 |
Multicentric Castleman disease | 260 |
Jessner-Kanof disease | 261 |
Primary Sjögren syndrome fatigue | 85 |
Kawasaki disease | 262 |
Colitis in chronic granulomatous disease | 263,264 |
Hidradenitis suppurativa | 265 |
Autoimmune inner ear disease | 100 |
Severe traumatic brain injury | 266 |